← FDA DRUG APPROVALS

FDA ANDA · ANDA040781

PHENYTOIN SODIUM

Sponsor: AM REGENT

APPLICATION
ANDA040781
TYPE
ANDA
ORIGINAL APPROVAL
2007-12-04
LATEST ACTION
2021-02-16
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

PHENYTOIN SODIUMDiscontinued
PHENYTOIN SODIUM 50MG/ML · INJECTABLE · INJECTION

Approval history

2021-02-16Labeling · Supplement 7 · standardAP
2021-01-22Labeling · Supplement 6 · standardAP
2015-10-05Labeling · Supplement 4 · standardAP
2015-10-05Labeling · Supplement 2 · standardAP
2015-10-05Labeling · Supplement 5 · standardAP
2007-12-04OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →